Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CNTB stock hub

Connect Biopharma Holdings Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CNTBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

133.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CNTB

In the news

Latest news · CNTB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-82.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-53.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CNTB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001835268
Company name	Connect Biopharma Holdings Limited
Country	United States
Country code	US
Cusip	G23549101
Employees	64
Employees Change	2%
Employees Change Percent	3.23
Enterprise value	$89.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-03-19
Isin	KYG235491019
Last refreshed	2026-05-10
Market cap	$133.4M
Market cap category	Micro-Cap
Price	$2.36
Price currency	USD
Rev Per Employee	1,000x
Sector	Healthcare
Sic	2834
Symbol	CNTB
Website	https://www.connectbiopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-41.59%
EV/Sales	1,402.16x
FCF yield	-38.71%
P/B ratio	3.17x
P/S ratio	2,084.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$64,000
Gross Profit Growth	-99.75%
Net Income	$-55.5M
Net Income Growth Years	0%
Pretax Margin	-86,379.69%
Profit Per Employee	$-866,875
ROA	-46.13
Roa5y	-28.6
ROCE	-136.8
ROE	-82.72
Roe5y	-113.3
ROIC	-53.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth	-99.75x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$56.1M
Cash	$44.3M
Current Assets	$50.9M
Current Liabilities	$13.6M
Debt	$690,000
Debt Equity	$0.02
Equity	$42M
Liabilities	$14.1M
Long Term Assets	$5.1M
Long Term Liabilities	$482,000
Net Cash	$43.7M
Net Cash By Market Cap	$32.73
Net Cash Growth	-53.33%
Net Debt Equity	$-1.04
Tangible Book Value	$41.9M
Tangible Book Value Per Share	$0.74
WACC	3.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.74
Net Working Capital	$-6.7M
Quick ratio	3.27
Working Capital	$37.3M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.81%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	2.73
All Time High	3.82
All Time High Change	-38.22%
All Time High Date	2026-03-27
All Time Low	1.23
All Time Low Change	91.87%
All Time Low Date	2025-09-30
ATR	0.21
Beta	-0.18
Beta1y	-3.55
Ch YTD	-16.31
High	2.4
High52	3.82
High52 Date	2026-03-27
High52ch	-38.22%
Low	2.27
Low52	1.23
Low52 Date	2025-09-30
Low52ch	91.87%
Ma50ch	-13.46%
Premarket Change Percent	5.15
Premarket Price	$2.45
Premarket Volume	30,503
RSI	39.22
RSI Monthly	0
RSI Weekly	49.1
Sharpe ratio	0.69x
Sortino ratio	1.17
Total Return	-0.81%
Tr YTD	-16.31
Tr1m	-16.31%
Tr1w	-4.45%
Tr3m	-2.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$10
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.28
Operating Income	$-58.1M
Operating margin	-90,740.6
Price target	$8.67
Price Target Change	$267
Price Target Change Top	$324

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,027,952%
Float Percent	21.28%
Shares Insiders	20.59%
Shares Institutions	12.55%
Shares Out	56,521,282
Shares Qo Q	0.63%
Shares Yo Y	0.81%
Short Ratio	2.3
Short Shares	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-55.4M
Average Volume	226,318.25x
Bv Per Share	0.74
CAPEX	$-434,000
Ch1m	-16.31
Ch1w	-4.45
Ch3m	-2.88
Ch6m	52.26
Change	1.29%
Change From Open	1.29
Close	2.33
Days Gap	0
Depreciation Amortization	704,000
Dollar Volume	224,688.5
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-58.1M
EBITDA	$-57.4M
EPS	$-1
F Score	1
FCF	$-51.6M
FCF EV Yield	-57.55x
FCF Per Share	$-0.91
Financing CF	1,093,000
Fiscal Year End	December
Founded	2,012
Income Tax	$197,000
Investing CF	9,818,000
Ipr	-86.12
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-31
Ma150	2.43
Ma150ch	-2.8%
Ma20	2.6
Ma20ch	-9.13%
Net CF	-39,887,000
Next Earnings Date	2026-05-22
Open	2.33
Optionable	Yes
Position In Range	72
Post Close	2.36
Postmarket Change Percent	1.7
Postmarket Price	$2.4
Ppne	4,455,000
Pre Close	2.33
Price Date	2026-05-08
Ptbv Ratio	3.18
Relative Volume	0.42x
Revenue	64,000x
SBC By Revenue	5,821.88x
Share Based Comp	3,726,000
Tax By Revenue	307.81x
Tr6m	52.26%
Us State	California
Volume	95,207
Z Score	-7.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CNTB pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns CNTB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.6%

Float: +21.3% of shares outstanding

Insider ownership

+20.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CNTB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

-0.18

Less volatile than the market

Sharpe ratio

0.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CNTB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CNTB stock rating?

Connect Biopharma Holdings Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CNTB analysis?

The full report lives at /stocks/CNTB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CNTB?

The latest report frames CNTB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CNTB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.